Cargando…

Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins

BACKGROUND: Melanoma is an aggressive tumor with increasing incidence. To develop accurate prognostic markers and targeted therapies, changes leading to malignant transformation of melanocytes need to be understood. In the Xiphophorus melanoma model system, a mutated version of the EGF receptor Xmrk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teutschbein, Janka, Haydn, Johannes M, Samans, Birgit, Krause, Michael, Eilers, Martin, Schartl, Manfred, Meierjohann, Svenja
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912872/ https://www.ncbi.nlm.nih.gov/pubmed/20663135 http://dx.doi.org/10.1186/1471-2407-10-386

Ejemplares similares

The MAPK pathway as an apoptosis enhancer in melanoma
por: Haydn, Johannes M., et al.
Publicado: (2014)

Lineage-specific co-evolution of the Egf receptor/ligand signaling system
por: Laisney, Juliette AGC, et al.
Publicado: (2010)

MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation
por: Meierjohann, Svenja, et al.
Publicado: (2010)

Hypoxia-Independent Drivers of Melanoma Angiogenesis
por: Meierjohann, Svenja
Publicado: (2015)

Whole Genome Duplications Shaped the Receptor Tyrosine Kinase Repertoire of Jawed Vertebrates
por: Brunet, Frédéric G., et al.
Publicado: (2016)

Histopathologic features of melanocytic tumors in Xiphophorus melanoma receptor kinase (xmrk)-transgenic medaka (Oryzias latipes)
por: Sugiyama, Akihiko, et al.
Publicado: (2019)

Conserved Expression Signatures between Medaka and Human Pigment Cell Tumors
por: Schartl, Manfred, et al.
Publicado: (2012)

BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1
por: Grimm, Johannes, et al.
Publicado: (2018)

NRF2 Enables EGFR Signaling in Melanoma Cells
por: Kreß, Julia Katharina Charlotte, et al.
Publicado: (2021)

The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma
por: Boregowda, Rajeev K., et al.
Publicado: (2016)

Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma
por: Koo, Karen, et al.
Publicado: (2023)

Gamma-secretase-dependent signaling of receptor tyrosine kinases
por: Merilahti, Johannes A.M., et al.
Publicado: (2018)

Receptor tyrosine kinases in carcinogenesis
por: Zhang, Xiao-Ying, et al.
Publicado: (2016)

Receptor tyrosine kinases in carcinogenesis
por: Zhang, Xiao-Ying, et al.
Publicado: (2020)

Tyrosine Kinase Receptors in Oncology
por: Esteban-Villarrubia, Jorge, et al.
Publicado: (2020)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
por: Pontara, Andrea, et al.
Publicado: (2020)

Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules
por: Leich, E, et al.
Publicado: (2013)

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
por: Stern, David F
Publicado: (2000)

Radiopharmacologist’s and Radiochemist’s View on Targeting the Eph/Ephrin Receptor Tyrosine Kinase System
por: Neuber, Christin, et al.
Publicado: (2020)

Receptor Tyrosine Kinases in Kidney Development
por: Song, Renfang, et al.
Publicado: (2011)

Receptor Tyrosine Kinases — Expanding Horizons
por: Hafizi, Sassan
Publicado: (2014)

Proteolytic Cleavage of Receptor Tyrosine Kinases
por: Huang, Hao
Publicado: (2021)

The Orphan Tyrosine Kinase Receptor, ROR2, Mediates Wnt5A Signaling in Metastatic Melanoma
por: O’Connell, Michael P., et al.
Publicado: (2009)

USP8 is a Novel Therapeutic Target in Melanoma Through Regulating Receptor Tyrosine Kinase Levels
por: Duan, Baoxue, et al.
Publicado: (2021)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
por: Xu, Haiyuan, et al.
Publicado: (2019)

Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
por: Demkova, Lucia, et al.
Publicado: (2018)

A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification
por: Dugo, Matteo, et al.
Publicado: (2015)

Prognostic value of receptor tyrosine kinases in malignant melanoma patients: A systematic review and meta-analysis of immunohistochemistry
por: Lei, Xuan, et al.
Publicado: (2022)

Endothelial receptor tyrosine kinases involved in angiogenesis
Publicado: (1995)

Receptor Tyrosine Kinases as Therapeutic Targets in Rhabdomyosarcoma
por: Crose, Lisa E. S., et al.
Publicado: (2011)

Receptor tyrosine kinases: role in cancer progression
por: Sangwan, V., et al.
Publicado: (2006)

Role of Receptor Tyrosine Kinases and Their Ligands in Glioblastoma
por: Carrasco-García, Estefanía, et al.
Publicado: (2014)

The Receptor Tyrosine Kinase AXL in Cancer Progression
por: Rankin, Erinn B., et al.
Publicado: (2016)

Flotillins in Receptor Tyrosine Kinase Signaling and Cancer
por: Banning, Antje, et al.
Publicado: (2014)

Mechanisms of receptor tyrosine kinase activation in cancer
por: Du, Zhenfang, et al.
Publicado: (2018)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
por: Pisick, Evan, et al.
Publicado: (2004)

Receptor Tyrosine Kinase-Targeted Cancer Therapy
por: Yamaoka, Toshimitsu, et al.
Publicado: (2018)

Ligand bias in receptor tyrosine kinase signaling
por: Karl, Kelly, et al.
Publicado: (2021)

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
por: Wu, Xinyan, et al.
Publicado: (2021)

The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma
por: Berning, Philipp, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mj91p30rakgpv0tko4tr7sk8ie